Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Chronic Cough”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Early research (Phase 1)Study completedNCT05226299
What this trial is testing

Cough Desensitization Therapy: Pilot 2

Who this might be right for
Cough
University of Montana 22
Very early researchUnknownNCT05813223
What this trial is testing

Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough

Who this might be right for
Chronic Cough
Stuart Mazzone 31
Early research (Phase 1)Study completedNCT03773068
What this trial is testing

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Who this might be right for
Biological Availability
Bayer 30
Testing effectiveness (Phase 2)Study completedNCT02612623
What this trial is testing

An 8-Week Refractory Chronic Cough Study (MK-7264-021)

Who this might be right for
Refractory Chronic Cough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Testing effectiveness (Phase 2)Study completedNCT05962151
What this trial is testing

Refractory Chronic Cough Improvement Via NAL ER (RIVER)

Who this might be right for
Refractory Chronic Cough
Trevi Therapeutics 66
Testing effectiveness (Phase 2)Study completedNCT05660850
What this trial is testing

Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Who this might be right for
Chronic Refractory Cough (CRC) With Non-atopic AsthmaCRC With Atopic AsthmaUnexplained Chronic Cough+2 more
Genentech, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT02349425
What this trial is testing

A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010)

Who this might be right for
Refractory Chronic Cough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 59
Not applicableUnknownNCT04078542
What this trial is testing

Prevalence and Main Features of Chronic Refractory Cough.

Who this might be right for
Cough
Campus Bio-Medico University 400
Early research (Phase 1)WithdrawnNCT07684586
What this trial is testing

Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes

Who this might be right for
Cough
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT03310645
What this trial is testing

Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients

Who this might be right for
Cough
Bayer 87
Large-scale testing (Phase 3)Study completedNCT05599191
What this trial is testing

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Who this might be right for
CoughRefractory Chronic Cough
Bellus Health Inc. - a GSK company 957
Very early researchStudy completedNCT04256733
What this trial is testing

Cough Desensitization Therapy for Cough Hypersensitivity Syndrome

Who this might be right for
Cough
University of Montana 19
Testing effectiveness (Phase 2)Study completedNCT02476890
What this trial is testing

Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)

Who this might be right for
Refractory Chronic Cough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 36
Testing effectiveness (Phase 2)Study completedNCT03622216
What this trial is testing

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

Who this might be right for
Chronic Cough
Attenua, Inc. 46
Not applicableUnknownNCT05570981
What this trial is testing

A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function

Who this might be right for
Chronic Refractory Cough
Bispebjerg Hospital 30
Testing effectiveness (Phase 2)UnknownNCT06246565
What this trial is testing

HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)

Who this might be right for
Cough
Jiangsu Hansoh Pharmaceutical Co., Ltd. 276
Not applicableStudy completedNCT03722849
What this trial is testing

Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients

Who this might be right for
Cough
Stuart Mazzone 58
Testing effectiveness (Phase 2)Looking for participantsNCT06960759
What this trial is testing

Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough

Who this might be right for
Chronic Cough (CC)Refractory Chronic CoughUnexplained Chronic Cough
University of Montana 135
Testing effectiveness (Phase 2)Looking for participantsNCT07690059
What this trial is testing

Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough

Who this might be right for
Refractory Chronic Cough and Unexplained Chronic Cough
Sensory Cloud, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02993822
What this trial is testing

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

Who this might be right for
Chronic Refractory Cough
Nerre Therapeutics Ltd. 315
Next Page